Eliminate the uncertainty of audit season with @340Best. Our seasoned advisors deliver HRSA Audit readiness and support services, giving you the confidence that your organization is fully prepared for the audit. Visit https://t.co/PlkRUnOjoA.
#AuditReady#340BProgram
Tim Walz, who has signed multiple 340B-related laws as governor of Minnesota, is the Democratic pick for vice president. Read @340B_Report’s article at https://t.co/NzF7kHYHpJ and learn more.
#340BReport#340Best
At #340Best, we're dedicated to ensuring our #340B healthcare clients operate smoothly & efficiently. Specializing in Administration, Audit, & Compliance Services, we take care of the complexities so you don't have to. https://t.co/9wxVPSXHvd.
#340BThirdPartyAdministration
The SUSTAIN 340B Act, a bipartisan Senate 340B program overhaul, has been delayed after its planned introduction on Aug. 1. Read @340B_Report’s article at https://t.co/dLqmbeKWkg and learn more.
#340BReport#340Best
Oregon Health & Science University Hospital is one of two 340B hospitals to sue HRSA over approving a drugmaker audit. Read @340B_Report’s article at https://t.co/y14UhwXu8B and learn more.
#340BReport#340Best
Due to Hurricane Beryl, certain Texas providers can immediately enroll in the #340B program without waiting for the normal registration period. Read @340B_Report’s article at https://t.co/UygjiGdZUb and learn more.
#340BReport#340Best
Over 60 advocates marched on Capitol Hill amid a heat wave in Washington, D.C. for the third annual "Defend 340B March". Read @340B_Report’s article at https://t.co/bWKf36VBNs to learn more.
#340BReport#340Best
AbbVie and AstraZeneca sued Kansas to block the state’s new contract pharmacy access law. Read @340B_Report’s article at https://t.co/w6SK9S2vjS to learn more.
#340BReport#340Best
The New York Times has filed a suit against the HRSA to obtain an order requiring the production of 340B-related records requested in November 2023 under the Freedom of Information Act. Read @340B_Report’s article at https://t.co/eX7Wv00G41.
#340BReport#340Best
Spending on pharmaceuticals in the 340B drug discount program went from nearly $7 billion in 2010 to $44 billion by 2021—a 19% annual increase—according to preliminary CBO estimates released this week. Read @340B_Report’s article at https://t.co/mjdgd3DlSH.
#340BReport#340Best
This week, a key West Virginia lawmaker rebuffed efforts to tie the 340B program to partisan politics. Read @340B_Report’s article at https://t.co/hfoLgyNR76 and learn more.
#340BReport#340Best